InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

AIM ImmunoTech Inc.

AIM Clue Score23
United States Fiscal year ends December CIK 0000946644
$0.18 +0.22% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.18 −93.10% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 17 Jun 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.1Operating income−13.8Net income−7.5Fiscal year 2017Revenue0.4 +375.0%Operating income−11.4Net income−8.3Fiscal year 2018Revenue0.4 −16.0%Operating income−11.5Net income−9.8Fiscal year 2019Revenue0.1 −61.9%Operating income−12.4Net income−9.4Fiscal year 2020Revenue0.2 +16.4%Operating income−15.2Net income−14.4Fiscal year 2021Revenue0.1 −17.2%Operating income−18.8Net income−19.1Fiscal year 2022Revenue0.1 +4.4%Operating income−19.9Net income−19.4EPS, diluted−0.40Fiscal year 2023Revenue0.2 +43.3%Operating income−31.9Net income−29.0EPS, diluted−0.60Fiscal year 2024Revenue0.2 −15.8%Operating income−19.8Net income−17.3EPS, diluted−30.92Fiscal year 2025Revenue0.1 −48.2%Operating income−11.7Net income−14.0EPS, diluted−8.62
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.1 0.4 0.4 0.1 0.2 0.1 0.1 0.2 0.2 0.1
Growth +375.0% −16.0% −61.9% +16.4% −17.2% +4.4% +43.3% −15.8% −48.2%
Operating income −13.8 −11.4 −11.5 −12.4 −15.2 −18.8 −19.9 −31.9 −19.8 −11.7
Net income −7.5 −8.3 −9.8 −9.4 −14.4 −19.1 −19.4 −29.0 −17.3 −14.0
Growth
EPS, diluted n/a n/a n/a n/a n/a n/a −0.40 −0.60 −30.92 −8.62

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−15,004.3%Net margin−8,154.3%Free cash flow margin−8,195.7%Fiscal year 2017Operating margin−2,612.4%Net margin−1,889.9%Free cash flow margin−1,821.7%Fiscal year 2018Operating margin−3,132.4%Net margin−2,677.7%Free cash flow margin−2,913.1%Fiscal year 2019Operating margin−8,887.9%Net margin−6,717.1%Free cash flow margin−6,525.0%Fiscal year 2020Operating margin−9,295.7%Net margin−8,834.4%Free cash flow margin−6,374.2%Fiscal year 2021Operating margin−13,954.1%Net margin−14,168.1%Free cash flow margin−10,374.8%Fiscal year 2022Operating margin−14,129.8%Net margin−13,790.8%Free cash flow margin−11,485.1%Fiscal year 2023Operating margin−15,800.0%Net margin−14,337.6%Fiscal year 2024Operating margin−11,630.6%Net margin−10,188.2%Free cash flow margin−8,768.2%Fiscal year 2025Operating margin−13,254.5%Net margin−15,861.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −15,004.3% −2,612.4% −3,132.4% −8,887.9% −9,295.7% −13,954.1% −14,129.8% −15,800.0% −11,630.6% −13,254.5%
Net margin −8,154.3% −1,889.9% −2,677.7% −6,717.1% −8,834.4% −14,168.1% −13,790.8% −14,337.6% −10,188.2% −15,861.4%
Free cash flow margin −8,195.7% −1,821.7% −2,913.1% −6,525.0% −6,374.2% −10,374.8% −11,485.1% n/a −8,768.2% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−7.4Capital expenditure−0.2Free cash flow−7.5Fiscal year 2017Operating cash flow−7.9Capital expenditure−0.0Free cash flow−8.0Fiscal year 2018Operating cash flow−10.6Capital expenditure−0.1Free cash flow−10.7Fiscal year 2019Operating cash flow−9.1Capital expenditure−0.1Free cash flow−9.1Fiscal year 2020Operating cash flow−10.4Capital expenditure−0.0Free cash flow−10.4Fiscal year 2021Operating cash flow−14.0Capital expenditure−0.0Free cash flow−14.0Fiscal year 2022Operating cash flow−16.1Capital expenditure−0.1Free cash flow−16.2Fiscal year 2023Operating cash flow−21.3Fiscal year 2024Operating cash flow−14.9Capital expenditure−0.0Free cash flow−14.9Fiscal year 2025Operating cash flow−11.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −7.4 −7.9 −10.6 −9.1 −10.4 −14.0 −16.1 −21.3 −14.9 −11.0
Capital expenditure −0.2 −0.0 −0.1 −0.1 −0.0 −0.0 −0.1 n/a −0.0 n/a
Free cash flow −7.5 −8.0 −10.7 −9.1 −10.4 −14.0 −16.2 n/a −14.9 n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash2.4Shareholders’ equity15.5Fiscal year 2017Cash1.4Shareholders’ equity8.7Fiscal year 2018Cash0.3Total debt2.5Net cash (debt)−2.2Shareholders’ equity5.6Debt to equity0.45Fiscal year 2019Cash1.5Total debt2.3Net cash (debt)−0.8Shareholders’ equity13.4Debt to equity0.17Fiscal year 2020Cash38.5Total debt2.1Net cash (debt)36.4Shareholders’ equity61.3Debt to equity0.03Fiscal year 2021Cash32.1Shareholders’ equity56.9Fiscal year 2022Cash27.1Shareholders’ equity38.5Fiscal year 2023Cash5.4Shareholders’ equity10.2Fiscal year 2024Cash1.7Total debt5.1Net cash (debt)−3.4Shareholders’ equity−1.3Fiscal year 2025Cash3.0Total debt4.5Net cash (debt)−1.5Shareholders’ equity−9.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 2.4 1.4 0.3 1.5 38.5 32.1 27.1 5.4 1.7 3.0
Total debt n/a n/a 2.5 2.3 2.1 n/a n/a n/a 5.1 4.5
Net cash (debt) n/a n/a −2.2 −0.8 36.4 n/a n/a n/a −3.4 −1.5
Shareholders’ equity 15.5 8.7 5.6 13.4 61.3 56.9 38.5 10.2 −1.3 −9.8
Debt to equity n/a n/a 0.45 0.17 0.03 n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
0.1 0.4 0.4 0.1 0.2 0.1 0.1 0.2 0.2 0.1
Growth +375.0% −16.0% −61.9% +16.4% −17.2% +4.4% +43.3% −15.8% −48.2%
5.1 4.1 4.8 4.7 5.7 7.7 7.0 10.9 6.2 3.9
7.7 6.6 6.2 7.0 8.7 8.7 13.1 21.1 13.7 7.7
−13.8 −11.4 −11.5 −12.4 −15.2 −18.8 −19.9 −31.9 −19.8 −11.7
Growth
n/a n/a n/a n/a n/a n/a n/a n/a n/a −14.0
−7.5 −8.3 −9.8 −9.4 −14.4 −19.1 −19.4 −29.0 −17.3 −14.0
Growth
Per share
n/a n/a n/a n/a n/a −0.40 −0.40 −0.60 −30.92 −8.62
n/a n/a n/a n/a n/a n/a −0.40 −0.60 −30.92 −8.62
Growth
n/a n/a n/a n/a n/a n/a n/a 48.6 0.6 1.6
n/a n/a n/a n/a n/a n/a 48.0 48.6 0.6 1.6
Growth +1.1% −98.8% +189.0%

† The diluted share count jumps at 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 11.6% a year over five years.
  • Operating margin is down 3,958.8 points on five years ago, at -13,254.5%.
  • A net loss in 10 of 10 years on file.